Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our intimation given vide our letter dated November 09, 2020 regarding declaration of Un-audited Financial Results for the quarter and half year ended September 30, 2020, we are enclosing herewith photocopy of the newspaper publications published in Business Standard, Mumbai (English version) on page no. 15 and in Mumbai Sakal (English version) on page no. 3 dated November 10, 2020 for your reference and record.
10-11-2020
Bigul

Fermenta Biotech Ltd - 506414 - Intimation Of Earnings Presentation For Quarter 2 - Financial Year 2020-2021

 Further to our intimation dated November 09, 2020 regarding approval of un-audited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and half year ended September 30, 2020, we hereby enclose a copy of Earnings Presentation for Quarter 2 - Financial Year 2020-2021. The said Earnings Presentation will thereafter be uploaded on Company's website at www.fermentabiotech.com Kindly take the same on record.
10-11-2020
Bigul

Fermenta Biotech Ltd - 506414 - Outcome Of Board Meeting And Unaudited Financial Results - Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')

 We write to inform you that the Board of Directors of the Company at its meeting held on November 09, 2020 has, inter alia, approved the unaudited financial results for the quarter and half year ended September 30, 2020 (Standalone and Consolidated) as enclosed. We are enclosing herewith Limited Review Report dated November 09, 2020 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, Deloitte Haskins & Sells LLP. Kindly take the above on record. The Board meeting commenced at 11.30 a.m. and concluded at 01.15 p.m.
09-11-2020
Bigul

Fermenta Biotech Ltd - 506414 - Outcome Of Board Meeting And Unaudited Financial Results - Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')

 We write to inform you that the Board of Directors of the Company at its meeting held on November 09, 2020 has, inter alia, approved the unaudited financial results for the quarter and half year ended September 30, 2020 (Standalone and Consolidated) as enclosed. We are enclosing herewith Limited Review Report dated November 09, 2020 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, Deloitte Haskins & Sells LLP. Kindly take the above on record. The Board meeting commenced at 11.30 a.m. and concluded at 01.15 p.m.
09-11-2020
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of Schedule of Analysts / Institutional Investors meeting over conference call under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. Pursuant to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting with the Analysts / Institutional Investors over conference call on Wednesday, November 11, 2020 at 11:00 a.m. to discuss the financial performance of the Company for the quarter ended September 30, 2020. The invite for the said conference call is enclosed herewith. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Host / Company.
05-11-2020
Bigul

Fermenta Biotech Ltd - 506414 - Reg 47 Of SEBI LODR - Publication Of Notice Of The Meeting Of Board Of Directors Scheduled On November 09, 2020

 Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our intimation given vide our letter dated November 03, 2020 (sent through BSE website) regarding meeting of the Board of Directors of the Company scheduled on November 09, 2020, we are enclosing herewith photocopy of the newspaper publication published in Business Standard, Mumbai (English version) on page no. 5 and Sakal, Mumbai (Marathi version) on page no. 7 dated November 04, 2020 for your reference and record.
04-11-2020
Bigul

Fermenta Biotech Ltd - 506414 - Closure of Trading Window

 Notice of Board Meeting to be held on Monday, November 09, 2020. In continuation with our earlier notice for the closure of trading window and in accordance with the provisions of Regulation 9 read with Schedule B of SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company''s Code of Conduct for Prevention of Insider Trading, the 'Trading Window" (period for trading in Company's securities) has been closed with effect from October 01, 2020 and shall continue to remain closed till 48 hours after the declaration of unaudited financial results for the quarter and half year ended September 30, 2020. During the closure of Trading Window, all Directors, Promoters, Insiders, Designated Persons including Auditors shall not, directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company's Equity Shares, either in their own name or in the name of their immediate relatives.
03-11-2020
Bigul

Fermenta Biotech Ltd - 506414 - Board Meeting Intimation for Notice Of Board Meeting And Closure Of Trading Window

 Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that meeting of the Board of Directors of the Company is scheduled to be held on Monday, November 09, 2020, inter alia, to consider and approve the unaudited financial results of the Company (standalone and consolidated) for the quarter and half year ended September 30, 2020.
03-11-2020
Bigul

Fermenta Biotech Ltd - 506414 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Certificate under Regulation 74(5) of SEBI (Depositories and Participants), Regulations 2018 for the quarter ended September 30, 2020 Pursuant to the provisions of Regulation 74(5) of SEBI (Depositories and Participants), Regulations 2018, for the quarter ended September 30, 2020, we hereby certify that on receipt of securities for dematerialization - a. The securities comprised in the said certificate(s) of security have been listed on the stock exchanges where the earlier securities are listed; b. The said certificate(s) after due verification have been mutilated and cancelled and the name of the depositories have been substituted in the register of members as the registered owner. The above is confirmed based on the certificate received from our Registrar and Transfer Agent - Link Intime India Private Limited, which is enclosed herewith.
28-10-2020
Bigul

Fermenta Biotech Ltd - 506414 - Compliance Certificate Under Regulation 40(9) Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations') For Half Year Ended September 30, 2020

 Pursuant to Regulation 40(9) of the Listing Regulations, we are enclosing Certificate dated October 20, 2020 issued by M/s V. N. Deodhar & Co., Company Secretaries, for the half year ended September 30, 2020.
27-10-2020
Next Page
Close

Let's Open Free Demat Account